Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms

Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic interfered in the daily lives of people and is assumed to adversely affect mental health. However, the effects on mood (in)stability of bipolar disorder (BD) patients and the comparison to pre‐COVID‐19 symptom severity levels are u...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Manja Koenders, Rahele Mesbah, Annet Spijker, Elvira Boere, Max deLeeuw, Bert vanHemert, Erik Giltay
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	bipolar disorder COVID‐19 depression loneliness mania stress Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/f24007f39c63434085c4327659288f59
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f24007f39c63434085c4327659288f59
record_format	dspace
spelling	oai:doaj.org-article:f24007f39c63434085c4327659288f592021-11-25T06:06:36ZEffects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms2162-327910.1002/brb3.2326https://doaj.org/article/f24007f39c63434085c4327659288f592021-11-01T00:00:00Zhttps://doi.org/10.1002/brb3.2326https://doaj.org/toc/2162-3279Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic interfered in the daily lives of people and is assumed to adversely affect mental health. However, the effects on mood (in)stability of bipolar disorder (BD) patients and the comparison to pre‐COVID‐19 symptom severity levels are unknown. Method Between April and September, 2020, symptoms and well‐being were assessed in the Bipolar Netherlands Cohort (BINCO) study of recently diagnosed patients with BD I and II. The questionnaire contained questions regarding manic and depressive symptoms (YMRS and ASRM, QIDS), worry (PSWQ), stress (PSS), loneliness, sleep, fear for COVID‐19, positive coping, and substance use. As manic, depressive and stress symptoms levels were assessed pre‐COVID‐19, their trajectories during the lockdown restrictions were estimated using mixed models. Results Of the 70 invited BD patients, 36 (51%) responded at least once (mean age of 36.7 years, 54% female, and 31% BD type 1) to the COVID‐19 assessments. There was a significant increase (X2 = 17.06; p = .004) in (hypo)manic symptoms from baseline during the first COVID‐19 wave, with a decrease thereafter. Fear of COVID‐19 (X2 = 18.01; p = .003) and positive coping (X2 = 12.44; p = .03) were the highest at the start of the pandemic and decreased thereafter. Other scales including depression and stress symptoms did not vary significantly over time. Conclusion We found a meaningful increase in manic symptomatology from pre‐COVID‐19 into the initial phases of the pandemic in BD patients. These symptoms decreased along with fear of COVID‐19 and positive coping during the following months when lockdown measures were eased.Manja KoendersRahele MesbahAnnet SpijkerElvira BoereMax deLeeuwBert vanHemertErik GiltayWileyarticlebipolar disorderCOVID‐19depressionlonelinessmaniastressNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain and Behavior, Vol 11, Iss 11, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	bipolar disorder COVID‐19 depression loneliness mania stress Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	bipolar disorder COVID‐19 depression loneliness mania stress Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Manja Koenders Rahele Mesbah Annet Spijker Elvira Boere Max deLeeuw Bert vanHemert Erik Giltay Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
description	Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic interfered in the daily lives of people and is assumed to adversely affect mental health. However, the effects on mood (in)stability of bipolar disorder (BD) patients and the comparison to pre‐COVID‐19 symptom severity levels are unknown. Method Between April and September, 2020, symptoms and well‐being were assessed in the Bipolar Netherlands Cohort (BINCO) study of recently diagnosed patients with BD I and II. The questionnaire contained questions regarding manic and depressive symptoms (YMRS and ASRM, QIDS), worry (PSWQ), stress (PSS), loneliness, sleep, fear for COVID‐19, positive coping, and substance use. As manic, depressive and stress symptoms levels were assessed pre‐COVID‐19, their trajectories during the lockdown restrictions were estimated using mixed models. Results Of the 70 invited BD patients, 36 (51%) responded at least once (mean age of 36.7 years, 54% female, and 31% BD type 1) to the COVID‐19 assessments. There was a significant increase (X2 = 17.06; p = .004) in (hypo)manic symptoms from baseline during the first COVID‐19 wave, with a decrease thereafter. Fear of COVID‐19 (X2 = 18.01; p = .003) and positive coping (X2 = 12.44; p = .03) were the highest at the start of the pandemic and decreased thereafter. Other scales including depression and stress symptoms did not vary significantly over time. Conclusion We found a meaningful increase in manic symptomatology from pre‐COVID‐19 into the initial phases of the pandemic in BD patients. These symptoms decreased along with fear of COVID‐19 and positive coping during the following months when lockdown measures were eased.
format	article
author	Manja Koenders Rahele Mesbah Annet Spijker Elvira Boere Max deLeeuw Bert vanHemert Erik Giltay
author_facet	Manja Koenders Rahele Mesbah Annet Spijker Elvira Boere Max deLeeuw Bert vanHemert Erik Giltay
author_sort	Manja Koenders
title	Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
title_short	Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
title_full	Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
title_fullStr	Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
title_full_unstemmed	Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
title_sort	effects of the covid‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: indications for increases in manic symptoms
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/f24007f39c63434085c4327659288f59
work_keys_str_mv	AT manjakoenders effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT rahelemesbah effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT annetspijker effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT elviraboere effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT maxdeleeuw effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT bertvanhemert effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms AT erikgiltay effectsofthecovid19pandemicinapreexistinglongitudinalstudyofpatientswithrecentlydiagnosedbipolardisorderindicationsforincreasesinmanicsymptoms
_version_	1718414198364438528

Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms

Ejemplares similares